BlueRock Therapeutics Competitors and Similar CompaniesClear all
BlueRock Therapeutics's competitors and similar companies include ACADIA Pharmaceuticals and Regenxbio.
 ACADIA Pharmaceuticals ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders. |  Regenxbio Regenxbio is a clinical-stage biotechnology company providing gene therapy product candidates for the treatment of retinal, metabolic, and neurodegenerative diseases. | ||
Founding Date | Founding Date 2016 | Founding Date 1993 | Founding Date 2009 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Cambridge, US HQ Toronto, CA Berlin, DE New York, US | Locations San Diego, US HQ Princeton, US | Locations Rockville, US HQ |
Employees | Employees 477 | Employees 513 | Employees 4018% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.4 b | Valuation ($) 447.8 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $1.1b (FY, 2025) | Revenue (est.) $170.4m (FY, 2025) |
Net income | Net income N/A | Net income $391m (FY, 2025) | Net income ($193.9m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 225m | Total funding raised $ 770.8m | Total funding raised $ 118.9m |
For sources of this data, please see the company profile
View Company Profiles
ACADIA Pharmaceuticals
HQ
San Diego, US
Employees
513
ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders.
View companyRegenxbio
HQ
Rockville, US
Employees
401↑ 8% increase
Regenxbio is a clinical-stage biotechnology company providing gene therapy product candidates for the treatment of retinal, metabolic, and neurodegenerative diseases.
View company